ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Key Considerations For Selecting Fill/Finish Manufacturing Technologies

  Obtaining information and proactively mapping out your fill/finish strategy early can de-risk an investment in equipment or processes, ensuring you meet your long-term needs.

• Overcoming Melt Processing Challenges

  Discover how a biodegradable polymer platform, easily applied with hot melt processing, enables processing at a relatively low temperature while preserving the potency of temperature-sensitive APIs.

• Enhancing The Solubility Of High Lipophilicity Drugs Via Spray Drying

  A new R&D project shows the solubility and dissolution characteristics of Itraconazole can be improved by helping them maintain an amorphous state after spray drying with selected hydrophilic polymers.

• A Lifecycle Management Strategy For Sterile Injectables

  Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.

• Key Considerations When Choosing A Device For Dry Powder Nasal Delivery

  Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.

• Faster From Formulation To Fill/Finish

  Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.

• Delivering Market Success For Pharma Partners From Concept To Patient

  The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies.

• The Paradigm Shift: From Scale-Up To Scale-Out In Genetic Medicine

  The shift from "scale-up" to "scale-out" in genetic medicine enhances production speed, revolutionizing pharmaceutical manufacturing and accelerating life-saving therapies for global patient populations.

• How Subcutaneous Delivery Can Help Patients Manage Chronic Conditions

  Read more about how to improve your patients’ outcomes, avoid costly delays to launch, and provide a better return on investment.

• Four Challenges That Stall Advanced Therapy Development

  Many challenges can stall an advanced therapy’s development, and the vast majority of them are tied to inadequate preclinical planning and partner vetting. Find how to foster a better development strategy.